Lung Cancer News

People with interstitial lung abnormalities have an increased risk for lung cancer and lung cancer mortality, but not other cancers, according to a study published in the European Respiratory Journal.

The FDA granted fast track designation to BDTX-189 for treatment of certain adults with solid tumors who progressed after prior therapy and have no satisfactory therapeutic treatment options.

The FDA granted breakthrough therapy designation to osimertinib for adjuvant treatment of certain patients with early-stage non-small cell lung cancer, according to the agent’s manufacturer.

J. Rob Headrick, MD, MBA, understands the psychology of smokers.

A gamma-delta T-cell therapy failed to significantly prolong PFS for patients with treatment-refractory non-small cell lung cancer, according to study results presented at American Association for Cancer Research Virtual Annual Meeting II.

An international research effort is underway to assess the effects of lung cancer treatment on women’s sexual health.

Individuals with a smoking history should begin annual screening for lung cancer at age 50 years instead of age 55 years, according to a draft recommendation issued by the U.S. Preventive Services Task Force.

Sarah B. Goldberg, MD, MPH, and colleagues conducted a phase 2 study to test the PD-1 inhibitor pembrolizumab among patients with stage IV non-small cell lung cancer and small brain metastases that had not been previously treated or had progressed after radiotherapy.

The Healio Editors have compiled a list of the most-read pulmonology news published in June.

Increased rates of certain infections, such as influenza, gastroenteritis, hepatitis and pneumonia, appeared associated with an eventual cancer diagnosis, according to research published in Cancer Immunology Research.